There are some aspects of this fund which may require extra consideration before deciding to invest.
Restrictions on acquisition
In this case, there are limits or exclusions on buying this investment that are important to know and acknowledge before you do.
Members of the public wishing to subscribe for shares can apply under two different offer pools: They must be allocated shares by a broker firm under the Broker Firm Offer; or must be eligible for shares as a resident in the Gisborne constituency which makes up the Gisborne District Council region, be a WIL shareholder or otherwise be invited to participate in the Priority Offer by Rua (determined by Rua in its sole discretion). You should contact your broker firm to determine whether you may be offered shares under the Broker Firm Offer.
Issuer's description of this product:
Fully paid ordinary shares
Minimum investment
This is the minimum amount you would need to put into this in order to invest.
Fixed offer price
This is the price per share of this offer. Additional details may be available.
Closing date
This is when this offer closes to investors.
Key facts
Provider website
Intending to list
The issuer has indicated that they are intending to list this investment on a public exchange, or that it is already listed. See the listing here: shareoffer.co.nz
Issuer's industry
Other
Fixed offer price details
Fixed offer price description
Rua Bioscience has set a fixed offer price of NZD0.50 per share. In determining the offer price, consideration was given to the level of demand for Shares in the bookbuild, the desire for a successful and consistent aftermarket for the Shares and the trading history of comparable listed medicinal cannabis companies.
Key documents
These are the most important documents that a provider is required to file about this investment.
Product disclosure statement
Before you invest in a product like a fund, you are given a PDS which has essential details about it and the company providing it. Here's more on how to read a PDS.
PDS.pdf
How this investment works, including about the provider, risks, costs and potential returns
Additional disclosure documents
These are more documents from the provider that can contain interesting information.
Other Material Information.pdf
Additional details
Issuer details
Name
RUA BIOSCIENCE LIMITED
Type
NZ Limited Company
Industry
Other
Website
NZBN
9429046397072
Credit rating
Not provided
Offer details
Date registered
25 September 2020
Date opened
05 October 2020
Closing date
16 October 2020
Continuous issue
No
Further payments may be required
No
Restrictions on transfer
No
Restrictions on acquisition
Yes: Members of the public wishing to subscribe for shares can apply under two different offer pools: They must be allocated shares by a broker firm under the Broker Firm Offer; or must be eligible for shares as a resident in the Gisborne constituency which makes up the Gisborne District Council region, be a WIL shareholder or otherwise be invited to participate in the Priority Offer by Rua (determined by Rua in its sole discretion). You should contact your broker firm to determine whether you may be offered shares under the Broker Firm Offer.
Convertible product
No
Intending to list
Yes : shareoffer.co.nz
Schedule 1 exemption
No
FMA exemption
No
Reference numbers
Offer
OFR12952: INITIAL PUBLIC OFFERING OF ORDINARY SHARES IN RUA BIOSCIENCE LIMITED
Next steps
Want to know more about this investment or how it compares to others? Have a look at its peers.
Product disclosure statement
Take a deeper dive into the PDS, which has essential details about this offer and the company providing it. Here's more on how to read a PDS.
Market listing
The provider has indicated they are intending to list this investment, or that it is already listed, on a public securities market. Here's where to find the market listing: shareoffer.co.nz
Getting investment advice
Good advice is gold. Everyone can benefit from expert advice, provided the adviser has your interests at heart. Here's how to find one and key questions to ask.
Interested in investing in this offer? Visit the provider's website. ruabio.com